Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes
Diabetic Medicine · 2025
DOI: 10.1111/dme.15476 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Danielle L Jones und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolic Science - Medical Research Laboratories, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Diabetes, Gestational, Blood Glucose, Health Equity. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EFSD/Novo Nordisk Foundation Future Leaders Award, NIHR Cambridge Biomedical Research Centre, NIHR Leicester Biomedical Research Centre.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objectives
Gestational diabetes is diagnosed using an oral glucose tolerance test (OGTT), which has limited accuracy, reproducibility and practicality. We assessed the effect of enhanced pre‐analytical glucose processing upon glucose concentrations, gestational diabetes diagnosis, health equity and pregnancy outcomes, and if HbA1c was a suitable alternative.
Methods
We recruited pregnant women with ≥1 risk factor to a prospective observational cohort study of pregnancy hyperglycaemia, endocrine causes, lipids, insulin and autoimmunity (OPHELIA), from nine UK centres. During a 75 g antenatal OGTT (National Institute of Health and Care Excellence criteria), standard glucose processing was compared to enhanced glucose processing (storage on ice, rapid centrifugation, aliquoting and freezing
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Metabolic Science - Medical Research Laboratories, University of Cambridge, Cambridge, UK.
- Leicester Diabetes Centre, University Hospitals Leicester & University of Leicester, Leicester, UK.
- Cambridge Universities NHS Foundation Trust, Cambridge, UK.
- Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.
- North West Anglia NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK.
- Salisbury NHS Foundation Trust, Salisbury District Hospital, Salisbury, UK.
ORCID-Profile: Claire L Meek
Förderung
- EFSD/Novo Nordisk Foundation Future Leaders Award
- NIHR Cambridge Biomedical Research Centre
- NIHR Leicester Biomedical Research Centre
- European Foundation for the Study of Diabetes
- Diabetes UK
Zitieren
APA
Jones, D. L., Kusinski, L. C., Barker, P., Burling, K., Halsall, I., Turner, E., Glenn-Sansum, C., Rand, A., Finch, J., Peters, G., Upson, G., Mullins, E., & Meek, C. L. (2025). Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes. Diabetic Medicine. https://doi.org/10.1111/dme.15476
Vancouver
Jones DL, Kusinski LC, Barker P, Burling K, Halsall I, Turner E, et al. Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes. Diabetic Medicine. 2025. doi:10.1111/dme.15476
BibTeX
@article{Jones2025,
author = {Jones, Danielle L and Kusinski, Laura C and Barker, Peter and Burling, Keith and Halsall, Ian and Turner, Elizabeth and Glenn-Sansum, Coralie and Rand, Abby and Finch, Jenny and Peters, Genessa and Upson, Geraldine and Mullins, Edward and Meek, Claire L},
title = {Enhanced glucose processing in gestational diabetes diagnosis: Effects on health equity and clinical outcomes},
journal = {Diabetic Medicine},
year = {2025},
doi = {10.1111/dme.15476}
}
EUVIMED